Reproductive Markers in Alzheimer's Disease Progression: The Framingham Heart Study

Area of Science:

• Reproductive health and neurodegenerative disease research.
• Gerontology and cognitive aging studies.
• Endocrinology and its impact on brain health.

Background:

• Reproductive factors like menarche and menopause age may influence cognitive function and Alzheimer's disease (AD) risk, but evidence is conflicting.
• The interaction between reproductive status and cortical beta-amyloid deposition in AD pathogenesis is not fully understood.

Purpose of the Study:

• To investigate the association between reproductive risk factors and sex hormone markers with cognitive decline in specific domains among women.
• To determine the relationship between reproductive history and the risk of developing Alzheimer's disease (AD) in older women.

Main Methods:

• Analysis of reproductive markers (age at menarche, number of births, age at menopause, sex hormone levels) in 772 women (aged 60+) from the Framingham Heart Study (FHS) Offspring cohort.
• Utilized Cox proportional hazards regression and linear regression models to assess associations with incident AD and annualized cognitive decline, adjusting for covariates.

Main Results:

• Older age at menopause was associated with a lower risk of incident AD dementia (6% lower risk per year) and slower memory decline.
• Lower plasma Aβ42 levels were linked to a higher risk of incident AD.
• No significant interaction was found between reproductive factors (menarche/menopause age, sex hormones) and Aβ42 pathology regarding AD risk or cognitive decline.

Conclusions:

• Younger age at menopause is identified as a risk factor for late-life memory decline and incident Alzheimer's disease (AD).
• The observed risk associated with earlier menopause appears independent of amyloid-beta (Aβ42) pathology.
• Further research is needed to elucidate the biological and social mechanisms driving the differential effects of reproductive risks on cognitive aging and AD.